ASCEND BY NTHRYS
Research Abroad Products

Molecular Dynamics Project Topics

Browse all focused areas across all project categories under this field.

Showing 157–168 of 200 project topics
Multi-Specificity Antibody Design Optimization Commercial Service
A managed service offering MD-driven design and validation of bispecific and multispecific antibodies with optimized domain orientations and inter-arm distances. Captures high-value project fees from pharma clients developing next-generation combination therapeutics.
Antibody MD Simulation Service Platforms Click to view more details →
Antibody Immunogenicity Risk Profiling Platform with MD Analytics
A commercial analytics platform predicting antibody immunogenicity and anti-drug antibody (ADA) risk through conformational MD simulations and epitope mapping. Reduces clinical trial failures and supports biotech valuations through demonstrated immunological safety profiling.
Antibody MD Simulation Service Platforms Click to view more details →
GPU-Accelerated Antibody Lead Optimization-as-a-Service Platform
A high-throughput SaaS offering rapid MD simulations for antibody lead optimization across binding kinetics, stability, and druggability metrics with enterprise API integrations. Generates recurring revenue through per-simulation usage-based pricing with enterprise licensing tiers.
Antibody MD Simulation Service Platforms Click to view more details →
Therapeutic Antibody Shelf-Life Prediction Commercial Software Suite
An enterprise software solution using MD simulations to predict long-term antibody stability, degradation pathways, and storage condition optimization for commercialized therapeutics. Supports regulatory submissions and manufacturing excellence, creating competitive advantages in product lifecycle management.
Antibody MD Simulation Service Platforms Click to view more details →
Real-time RNA Folding Prediction SaaS Platform
A cloud-based platform that simulates RNA secondary and tertiary structure folding in real-time using GPU-accelerated MD algorithms. Enables pharmaceutical and biotech companies to rapidly screen RNA therapeutics and reduce drug candidate discovery timelines by 60%.
RNA & Nucleic Acid MD Simulation Services Click to view more details →
CRISPR-Cas9 Off-target Binding Simulation Engine
Commercial software that uses molecular dynamics to predict and visualize off-target binding sites for CRISPR guide RNA sequences before clinical deployment. Reduces regulatory approval delays and liability risks by identifying potential off-target effects in preclinical phases.
RNA & Nucleic Acid MD Simulation Services Click to view more details →
DNA-Protein Interaction Kinetics Benchmarking Service
A high-throughput MD simulation service that calculates binding kinetics, residence times, and thermodynamic profiles for DNA-protein complexes at scale. Generates competitive advantage for diagnostic and therapeutic companies through proprietary binding data monetization.
RNA & Nucleic Acid MD Simulation Services Click to view more details →
mRNA Vaccine Stability and Degradation Modeling Tool
A specialized MD platform that simulates mRNA structural degradation pathways and predicts in vivo stability under various conditions and formulation matrices. Accelerates vaccine development cycles and enables premium pricing for stability-optimized mRNA therapeutics.
RNA & Nucleic Acid MD Simulation Services Click to view more details →
Nucleotide Analog Incorporation Efficiency Prediction Software
Cloud-based tool leveraging MD to simulate how synthetic nucleotide analogs integrate into DNA/RNA strands and affect polymerase kinetics. Creates licensing revenue for biotech firms developing next-generation sequencing or synthetic biology reagents.
RNA & Nucleic Acid MD Simulation Services Click to view more details →
Aptamer-Target Affinity Optimization and Screening Platform
An enterprise MD service that rapidly screens and optimizes RNA aptamer sequences against therapeutic targets by simulating binding thermodynamics and kinetics. Enables faster aptamer drug development and increases hit-to-lead conversion rates by 40%.
RNA & Nucleic Acid MD Simulation Services Click to view more details →
Antisense Oligonucleotide Hybridization Prediction Engine
A commercial-grade MD tool that predicts off-target mRNA binding and secondary structure interference for antisense drug candidates. Reduces failed clinical trials and regulatory rejections by quantifying specificity metrics before IND filing.
RNA & Nucleic Acid MD Simulation Services Click to view more details →
Quadruplex Stabilization and Drug Binding Simulation Suite
A specialized platform for simulating G-quadruplex and i-motif DNA structures and their interactions with small molecule stabilizers and drugs. Creates IP-protected screening services for oncology and genetic disease companies targeting quadruplex-forming regions.
RNA & Nucleic Acid MD Simulation Services Click to view more details →